MILabs realizes a breakthrough in preclinical oncology imaging by eliminating the positron range effect of 89Zr-immunoPET
February 15, 2020 – Utrecht, the Netherlands Researchers at MILabs B.V. have succeeded at imaging the popular Zirconium-89 (89Zr) isotope in small animals of human disease at very high resolutions (<0.75 mm). 89Zr as used …
The University of Lausanne installs a high-end MILabs’ Duet Optical Imager in its core In-Vivo Imaging Laboratory
Lausanne-Switzerland and Utrecht-the Netherlands, 14 February 2020 The University of Lausanne (UNIL) and the Lausanne University Hospital (CHUV) have acquired MILabs latest in-vivo optical imaging and diagnostic X-ray CT systems. The systems will be installed …
Lund University Bioimaging Center (LBIC) extends its preclinical imaging capabilities with MILabs’ new diagnostic X-Ray CT system.
January 6, 2020 – Lund-Sweden and Utrecht, the Netherlands The Bioimaging Center of Lund University is a leading trans-faculty research center that houses a wide range of advanced preclinical and clinical imaging equipment. To further …
Kawasaki Medical University installs first MILabs E-Class U-SPECT6/CT in Japan
Kurashiki, Okayama, Japan and Utrecht, the Netherlands, 20 August 2019. Kawasaki Medical University, Yokohama’s research hub for state-of-the-art medical science and services has acquired an ultra-high-resolution E-Class U-SPECT6/CT system for preclinical imaging. E-Class stands for …
The Innovation Center for Translational Imaging of Tel Aviv University acquires MILabs VECTor PET/SPECT/CT system
The Innovation Center for Translational Imaging of Tel Aviv University acquires MILabs VECTor PET/SPECT/CT system Tel Aviv and Utrecht, July 8 2019 – Tel Aviv University’s (TAU) new Translational Medical Research Center has acquired a …
UT Dallas acquires new microCT-enhanced deep-tissue Optical Imaging system.
The Department of Bioengineering at the UT Dallas is adding a MILabs Hybrid OI/CT system to its innovative medical imaging solutions. By fusing bioluminescent and fluorescent imaging with ultra-high-resolution CT, this new in-vivo imaging system …
MILabs Selected by Columbia University Irving Medical Center For Upgrades to its Molecular Imaging Capabilities
Utrecht, the Netherlands, February 15, 2019 The MILabs VECTor (OI/CT) system has been acquired by the Department of Radiology at Columbia University Irving Medical Center (CUIMC) to upgrade its molecular imaging capabilities. MILabs VECTor system …
The Baker Heart & Diabetes Institute invests in MILabs’ in-vivo Hybrid Optical/CT tomography to support its groundbreaking platelet research
Melbourne, Australia, and Utrecht, the Netherlands, April 24 2019 – The Baker Heart and Diabetes Institute, an independent Australian-based research institute recognized internationally for its groundbreaking work on the function of platelets in heart disease …
MILabs installs new E-Class SPECT/CT system to enhance heart failure research at the Comprehensive Heart Failure Center (CHFC), Würzburg, Germany
Würzburg, Germany and Utrecht, the Netherlands The nuclear cardiology core facility of the CHFC-Würzburg has acquired MILabs E-class SPECT/CT system to enhance its existing top-level basic, translational and clinical research activities in the field of …
MILabs announces the first installation in Poland of its pre-clinical Adaptive microCT scanner
The Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology (FBBB) at the Jagiellonian University in Kraków recently became the first institute in Poland to install MILabs’ Adaptive U-CT for in-vivo preclinical imaging. To accommodate …
